Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
|Articles|October 1, 2002
Supplements and Featured Publications
- Cardiorenal Differences Among NSAIDs and Coxibs: Real-World Experience
- Volume 8
- Issue 15 Suppl
Comparison of the Baseline Cardiovascular Risk Profile Among Hypertensive Patients Prescribed COX-2-Specific Inhibitors or Nonspecific NSAIDs: Data From Real-Life Practice
Advertisement
Articles in this issue
about 24 years ago
Participating Facultyabout 24 years ago
Cardiorenal Differences Among NSAIDs and Coxibs: Real-World ExperienceAdvertisement
Related to this article
Alice Hall-Partyka, JD, a partner at Crowell & Moring explains the lawsuits challenging CMS' Medicaid rule on pediatric gender care and its legal weak points.
Siva Mohan, MD, explains how drug costs drive silent nonadherence, PA burden, and biosimilar hesitancy, and what payers can do about it.
Proinflammatory diets were tied to higher mortality in MASLD and MetALD, whereas antioxidant-rich diets tracked with better survival.
Inconsistent definitions limit pathological response as a soft tissue sarcoma marker, according to a narrative review.
A meta-analysis of HELIOS-B and CARDIO-TTRansform found gene silencers reduced death and CV events, driven by patients not taking stabilizers.
ApoB more directly reflects atherogenic particle burden than LDL-C, but missing outcome trials and assay variability still limit its routine use.
An analysis finds distinct adverse event reporting patterns across immunosuppressive regimens, highlighting the need for tailored safety monitoring.
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About the One Big Beautiful Bill Act
2
ACA Subsidies End for 189,000 Duplicate or Deceased Enrollees
3
Coroner Reports Pennsylvania's Sixth Measles-Associated Death
4
FAQ: How Payers Can Close HIV Prevention and PrEP Access Gaps
5